More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

A new blood test could diagnose pancreatic cancer much earlier, improving survival rates for people with the disease. A large part of the reason for this poor prognosis is that pancreatic cancer is ...

INDIANAPOLIS (WISH) — About 64,000 Americans will be diagnosed with pancreatic cancer this year. Pancreatic cancer grows silently with very few symptoms. Doctors often don’t catch it until it’s in the ...

A new blood test developed by researchers at Oregon Health & Science University (OHSU) shows promise for the early detection of pancreatic cancer, a disease notorious for its high mortality rates due ...

NEW ORLEANS -- Pancreatic cancer kills swiftly and surely, and often goes undiagnosed until it's far too late for doctors to provide the only cure: surgery. But new research being reported here this ...

Successful treatment of pancreatic cancer can depend on a timely diagnosis. Various tests can help doctors rule out cancer or decide whether further testing is necessary. According to the American ...

A novel combination blood test detected nearly 70% of pancreatic cancers with a false-positive rate less than 5%, according to study findings published in Clinical Cancer Research. CA19-9 — an antigen ...

Exocrine pancreatic insufficiency (EPI) develops when the pancreas can’t make enough digestive enzymes to allow the absorption of crucial nutrients from food. This can lead to malnutrition and other ...

A next-generation biomarker-based blood test demonstrated 98% specificity and 75% sensitivity in detecting stage I and II pancreatic ductal adenocarcinoma, according to a press release from the ...

Exocrine pancreatic insufficiency (EPI) causes clay-colored, greasy stools that smell foul. A stool test to check for low levels of the elastase enzyme can help diagnose the condition. The pancreas ...

Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...